The Nrf-2/ARE-HO-1 axis: An important therapeutic approach for attenuating myocardial ischemia and reperfusion injury-induced cardiac remodeling

International Journal of Cardiology

Volumn 184, Issue 1, 2015, Pages 263-264

  Wang, Jichun ^a   Hu, Xiaorong ^a   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Cardiac remodeling; Heme oxygenase 1; Nuclear factor erythroid 2 (NF E2) related factor 2

Indexed keywords

HEME OXYGENASE 1; TRANSCRIPTION FACTOR NRF2; ARYLESTERASE; CARBOXYLESTERASE; HMOX1 PROTEIN, HUMAN; NFE2L2 PROTEIN, HUMAN;

AORTA CONSTRICTION; CARDIAC REMODELING; HEART DISEASE; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; LETTER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REPERFUSION INJURY; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HUMAN; METABOLISM; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; PHYSIOLOGY; PROCEDURES;

ANIMALS; CARBOXYLIC ESTER HYDROLASES; HEME OXYGENASE-1; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; NF-E2-RELATED FACTOR 2; VENTRICULAR REMODELING;

EID: 84933497636     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.02.073     Document Type: Article

References (12)

1. G. Takemura, M. Nakagawa, H. Kanamori, S.Minatoguchi, H. Fujiwara, Benefits of reperfusion beyond infarct size limitation, Cardiovasc. Res. 83 (2009) 269-276.
2. Y. Sun, Myocardial repair/remodelling following infarction: roles of local factors, Cardiovasc. Res. 81 (2009) 482-490.
3. C.E. Murdoch, M. Zhang, A.C. Cave, A.M. Shah, NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure, Cardiovasc. Res. 71 (2006) 208-215.
4. B.M. Hybertson, B. Gao, S.K. Bose, J.M. McCord, Oxidative streß in health and disease: The therapeutic potential of Nrf2 activation, Mol. Aspects Med. 32 (2011) 234-246.
5. J. Li, T. Ichikawa, L. Villacorta, J.S. Janicki, G.L. Brower, M. Yamamoto, et al., Nrf2 protects against maladaptive cardiac responses to hemodynamic streß, Arterioscler. Thromb. Vasc. Biol. 29 (2009) 1843-1850.
6. X.H. Li, C.Y. Li, Z.G. Xiang, J.J. Hu, J.M. Lu, R.B. Tian, et al., Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways, Cardiovasc. Drugs Ther. 26 (2012) 457-465.
7. S. Zhou, W. Sun, Z. Zhang, Y. Zheng, The role of Nrf2-mediated pathway in cardiac remodeling and heart failure, Oxid. Med. Cell. Longev. 2014 (2014) 260429.
8. C.M. Hu, Y.H. Chen, M.T. Chiang, L.Y. Chau, Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo, Circulation 110 (2004) 309-316.
9. J.F. Ndisang, A. Jadhav, Upregulating the heme oxygenase system suppreßes left ventricular hypertrophy in adult spontaneously hypertensive rats for 3 months, J. Card. Fail. 15 (2009) 616-628.
10. S.Mito, R. Ozono, T. Oshima, Y. Yano, Y.Watari, Y. Yamamoto, et al., Myocardial protection against preßure overload in mice lacking Bach1, a transcriptional repreßor of heme oxygenase-1, Hypertension 51 (2008) 1570-1577.
11. J. Wang, X. Hu, H. Jiang, Nrf-2-HO-1-HMGB1 axis: An important therapeutic approach for protection against myocardial ischemia and reperfusion injury, Int. J. Cardiol. 172 (2014) 223-224.
12. J. Wang, H. Yang, X. Hu, W. Fu, J. Xie, X. Zhou, et al., Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo, J. Surg. Res. 183 (2013) 509-516.